14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OPXA
Delisted

Opexa Therapeutics Fund Price (Quote)

$0.97
+0 (+0%)
At Close: Jan 16, 2018

Range Low Price High Price Comment
30 days $0.97 $0.97 Tuesday, 16th Jan 2018 OPXA stock ended at $0.97. During the day the stock fluctuated 0% from a day low at $0.97 to a day high of $0.97.
90 days $0.97 $0.97
52 weeks $0.550 $1.45

Historical Opexa Therapeutics prices

Date Open High Low Close Volume
Jan 16, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 15, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 12, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 11, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 10, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 09, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 08, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 05, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 04, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 03, 2018 $0.97 $0.97 $0.97 $0.97 0
Jan 02, 2018 $0.97 $0.97 $0.97 $0.97 0
Dec 29, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 28, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 27, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 22, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 21, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 20, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 19, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 18, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 15, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 14, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 13, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 12, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 11, 2017 $0.97 $0.97 $0.97 $0.97 0
Dec 08, 2017 $0.97 $0.97 $0.97 $0.97 0
Click to get the best stock tips daily for free!

About Opexa Therapeutics

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company’s lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy t... OPXA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT